CapsoVision, Inc (CV)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in CapsoVision, Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Based on dividend-adjusted daily data since Jul 2, 2025, CV's average daily return is +0.61%, while the average monthly return is +14.69%. At this rate, your investment would double in approximately 0.4 years.

Historically, 78% of months were positive and 22% were negative. The best month was Dec 2025 with a return of +91.2%, while the worst month was Jan 2026 at -53.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 1 months.

On a daily basis, CV closed higher 51% of trading days. The best single day was Dec 10, 2025 with a return of +32.7%, while the worst single day was Jan 5, 2026 at -17.1%.

CapsoVision, Inc has an annualized alpha of 330.64%, beta of 1.06, and R² of 0.01 versus S&P 500 Index. Calculated based on daily prices since July 03, 2025.

• This stock tended to rise when S&P 500 Index fell (downside capture of -26813.07%), but participation in market rallies was also limited (-180.11%) — a profile typical of counter-cyclical assets.
• R² of 0.01 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

The table below present risk-adjusted performance metrics for CapsoVision, Inc (CV) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the CapsoVision, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the CapsoVision, Inc was 67.82%, occurring on Feb 19, 2026. The portfolio has not yet recovered.

The current CapsoVision, Inc drawdown is 49.45%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of CapsoVision, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how CapsoVision, Inc is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.